Make more informed purchasing decisions with our new product availability and delivery estimate feature, now available on all product pages, in your cart, and during checkout.

“CV2002: SARS-CoV-2 Nucleocapsid Protein” has been added to your cart. View cart

CV1001: SARS-CoV 3CLPro

LifeSensors CV1001 offers advanced ubiquitin proteasome research tools with TUBE-based affinity matrices and mass spec assays for precise protein analysis and drug discovery.

$1,025.00

In stock

Product Advantages

Applications

Background

Within the last two decades, SARS and MERS coronaviruses emerged as global health concerns causing severe acute respiratory syndromes. In December 2019, a novel coronavirus (SARS-CoV-2) was identified in Wuhan, Hubei province in China. The SARS-CoV genome encodes several proteases including chymotrypsin-like protease (CLPro; 3CLp); this key enzyme along with PLPro and PLP2 (PLPro2) drives the early stage of infection by processing a large viral polypeptide into functional enzymes. This process is essential for the replication of the virus. SARS-CoV 3CLPro shares a 96% identity in protein sequence with 3CLPro from SARS-CoV-2. The 3CLPro represents an antiviral drug target for counteracting SARS-CoV and MERS-CoV infections.

Info

Species	SARS-CoV
Source	E. coli
Tag	None
Molecular Weight	34 kDa
Quantity	100 µg
Concentration	Variable
Formulation
Storage	-80^o C. Avoid repeated freeze/thaw cycles.